244 related articles for article (PubMed ID: 27861542)
21. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
22. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Pichler M; Hutterer GC; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R
Br J Cancer; 2013 Sep; 109(5):1123-9. PubMed ID: 23922109
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Nunno VD; Mollica V; Gatto L; Santoni M; Cosmai L; Porta C; Massari F
Immunotherapy; 2019 May; 11(7):631-643. PubMed ID: 30943858
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum total cholesterol is a predictor of prognosis in patients with renal cell carcinoma: a meta- analysis of observational studies.
Li B; Huang D; Zheng H; Cai Q; Guo Z; Wang S
Int Braz J Urol; 2020; 46(2):158-168. PubMed ID: 31961621
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1/PD-L1 therapy: A meta-analysis.
Xu J; Zhao J; Wang J; Sun C; Zhu X
Medicine (Baltimore); 2021 Apr; 100(14):e25318. PubMed ID: 33832106
[TBL] [Abstract][Full Text] [Related]
26. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature.
Men H; Liang C; Yu M
J Cancer Res Ther; 2015; 11(1):67-72. PubMed ID: 25879339
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.
Zhang J; Yao YH; Li BG; Yang Q; Zhang PY; Wang HT
Sci Rep; 2015 Apr; 5():9800. PubMed ID: 25902419
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Role of Lactate Dehydrogenase Expression in Urologic Cancers: A Systematic Review and Meta-Analysis.
Zhang Y; Xu T; Wang Y; Zhang H; Zhao Y; Yang X; Cao Y; Yang W; Niu H
Oncol Res Treat; 2016; 39(10):592-604. PubMed ID: 27710971
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
31. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
Front Oncol; 2020; 10():677. PubMed ID: 32509573
[No Abstract] [Full Text] [Related]
33. Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies.
Gan J; Wang W; Yang Z; Pan J; Zheng L; Yin L
Medicine (Baltimore); 2018 Nov; 97(46):e13151. PubMed ID: 30431587
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.
Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies.
Chen L; Li H; Gu L; Ma X; Li X; Gao Y; Zhang Y; Shen D; Fan Y; Wang B; Bao X; Zhang X
Medicine (Baltimore); 2015 Jul; 94(26):e1055. PubMed ID: 26131819
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.
Petrelli F; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Barni S
Acta Oncol; 2015 Jul; 54(7):961-70. PubMed ID: 25984930
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
38. Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
Powles T; Choueiri TK; Motzer RJ; Jonasch E; Pal S; Tannir NM; Signoretti S; Kaldate R; Scheffold C; Wang E; Aftab DT; Escudier B; George DJ
BMC Cancer; 2021 Aug; 21(1):904. PubMed ID: 34364385
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
Hu K; Lou L; Ye J; Zhang S
BMJ Open; 2015 Apr; 5(4):e006404. PubMed ID: 25854964
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
